Rigel Pharmaceuticals
RIGL
#6719
Rank
NZ$0.82 B
Marketcap
$46.77
Share price
0.70%
Change (1 day)
243.91%
Change (1 year)

Rigel Pharmaceuticals (RIGL) - Total debt

Total debt on the balance sheet as of June 2024 : NZ$0.10 Billion

According to Rigel Pharmaceuticals's latest financial reports the company's total debt is NZ$0.10 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Rigel Pharmaceuticals - Total debt on balance sheet (from 2000 to 2024)

Total debt by year

Year Total debt Change
2023-12-31NZ$95.79 M46.36%
2022-12-31NZ$65.44 M46.26%
2021-12-31NZ$44.74 M-17.4%
2020-12-31NZ$54.17 M0.47%
2019-12-31NZ$53.91 M
2018-12-31N/A
2011-12-31N/A-100%
2010-12-31NZ$1.03 M-61.26%
2009-12-31NZ$2.67 M-54.21%
2008-12-31NZ$5.84 M152.38%
2007-12-31NZ$2.31 M-30.6%
2006-12-31NZ$3.33 M3.58%
2005-12-31NZ$3.22 M9.36%
2004-12-31NZ$2.94 M-45.21%
2003-12-31NZ$5.37 M-50.64%
2002-12-31NZ$10.89 M-38.99%
2001-12-31NZ$17.85 M-13.18%
2000-12-31NZ$20.56 M40.41%
1999-12-31NZ$14.64 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$49.64 M-51.77%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$57.21 B 55,481.71%๐Ÿ‡ฌ๐Ÿ‡ง UK
NZ$103.05 B 100,011.05%๐Ÿ‡บ๐Ÿ‡ธ USA